Cited by 104Sirtuins and Resveratrol in MedicineAdipose Tissue and MetabolismPeroxisome Proliferator-Activated Receptors

Delipidating effect of resveratrol metabolites in 3 T 3‐L 1 adipocytes

Lasa, Arrate, Churruca, Itziar, Eseberri, Itziar, Andrés‐Lacueva, Cristina, Portillo, María P.·2012·Molecular Nutrition & Food Research

Abstract

Scope: Due to the low bioavailability of resveratrol, determining whether its metabolites exert any beneficial effect is an interesting issue. Methods and results: 3 T 3‐L 1 maturing pre‐adipocytes were treated from day 0 to day 8 of differentiation and mature adipocytes for 24 h on day 12 with 1, 10, or 25 μM of resveratrol or its metabolites. Triacylglycerols were assessed by spectrophotometry and gene expression by real time RT‐PCR. Resveratrol, trans‐resveratrol‐4′‐O‐glucuronide and trans‐resveratrol‐3‐O‐sulfate reduced triacylglycerol content in maturing pre‐adipocytes at 25 μM. In mature adipocytes, both resveratrol and its glucuronide metabolites, though not sulfate metabolite, reduced triacylglycerol content, although resveratrol was more effective than them. Resveratrol and the three metabolites reduced C/EBP β m RNA levels. Trans‐resveratrol‐3‐O‐sulfate also reduced C/EBP‐α, peroxisome proliferator‐activated receptor γ (PPAR‐γ), and lipoprotein lipase (LPL) expression. In mature adipocytes, resveratrol increased ATGL, CPT‐1, deacetylase sirtuin 1 (SIRT‐1), and PGC 1‐α expression. Trans‐resveratrol‐3‐O‐glucuronide reduced m RNA levels of FASN and increased those of SIRT‐1. Trans‐resveratrol‐4′‐O‐glucuronide increased HSL and SIRT‐1 m RNA levels. Trans‐resveratrol‐3‐O‐sulfate did not change gene expression. Conclusion: The present study shows for the first time the delipidating effect of (i) resveratrol metabolites in maturing pre‐adipocytes and (ii) glucuronide metabolites in mature adipocytes. This suggests that both resveratrol and resveratrol metabolites may be involved in the anti‐obesity effect of this polyphenol.

Integrity signals

Registry

Crossref · 10.1002/mnfr.201100772

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Resveratrol has an inhibitory effect on lipoprotein lipase.

    “Hence, these results suggest the presence of an inhibitory effect of resveratrol on lipoprotein lipase [18].”

    From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [18]

  • Lasa et al. reported that incubating pre-adipocyte cells with increasing concentrations of resveratrol (1, 10, and 25 μM) for 24 h decreased triacylglycerol content and lower expression of ACC.

    “Lasa and colleagues [18] incubated pre-adipocyte cells with increasing concentrations of resveratrol (1, 10, and 25 µM) for 24 h, reporting a decrease in triacylglycerol content and a lower expression of acetyl-CoA carboxylase (ACC).”

    From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [18]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lasa, A., Churruca, I., Eseberri, I., Andrés‐Lacueva, C., & Portillo, M. P.
Affiliations
  • University of the Basque Country (ES)
  • Universitat de Barcelona (ES)
Corresponding author
Portillo, María P.
Venue
Molecular Nutrition & Food Research
Publisher
Wiley
Published
2012-09-04
Volume
56
Issue
10
Pages
1559-1568
ISSN
  • 1613-4125 (ISSN-L)
  • 1613-4133
OpenAlex
W2054003772
Cited by
103
References
49
Citations by year
2026: 2 · 2025: 8 · 2024: 7 · 2023: 9 · 2022: 2 · 2021: 3 · 2020: 13 · 2019: 7 · 2018: 7 · 2017: 5 · 2016: 5 · 2015: 8 · 2014: 13 · 2013: 13
FWCI
5.33
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Nutrition & Food Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministerio de Ciencia e Innovación (AGL2008-01005-ALI)
  • Ministerio de Economía y Competitividad (AGL2011-27406-ALI)
  • Government of País Vasco (IT386-10, MICRORES S-PE11UN094)
  • University of the Basque Country UPV/EHU (ELDUNANOTEK UFI11/32)
  • Instituto de Salud Carlos III
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
resveratrol, resveratrol metabolites, adipocytes, adipogenesis, lipolysis, C/EBPβ, PPARγ, lipoprotein lipase, SIRT1, PGC-1α, adipose triglyceride lipase, HSL, fatty acid synthase, anti-obesity, polyphenols
MeSH terms
Resveratrol, Animals, Cell Differentiation, Gene Expression Regulation, Lipoprotein Lipase, RNA, Messenger, Stilbenes, Triglycerides, Adipocytes, Anti-Obesity Agents, Glucuronides, 3T3-L1 Cells, PPAR gamma, Mice, Real-Time Polymerase Chain Reaction, Fatty Acid Synthases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review